Bone metabolism in patients with osteonecrosis of the femoral head based on etiology and Association Research Circulation Osseous staging

doi:10.12307/2024.282

Abstract

Abstract: BACKGROUND: Currently, there is a lack of large sample studies to analyze the bone metabolism level of patients with femoral head necrosis of different etiologies and stages, which is not conducive to the development of better necrosis-promoting repair strategies.
OBJECTIVE: To study the bone metabolism of patients with osteonecrosis of the femoral head with different etiologies and Association Research Circulation Osseous (ARCO) stages.
METHODS: A retrospective study was performed on 401 patients diagnosed with osteonecrosis of the femoral head as the trial group, and 81 healthy subjects as the control group. The trial group could be divided into three groups according to different etiologies: steroid-induced osteonecrosis of the femoral head, alcoholic osteonecrosis of the femoral head and traumatic osteonecrosis of the femoral head, and were divided into stages II /III /IV according to different ARCO stages. Seven bone metabolism-related indicators of all subjects were collected, including bone metabolism-regulating hormone 25-hydroxyvitamin D and bone conversion markers: N-terminal propeptide of type I procollagen, degradation product of type I collagen, n-terminal middle molecular fragment of osteocalcin, general biochemical markers of bone metabolism: serum calcium, serum phosphorus, serum alkaline phosphatase. The bone metabolism levels of each group were compared and the independent factors associated with osteonecrosis of the femoral head were determined by binary Logistic regression analysis.
RESULTS AND CONCLUSION: Compared with the control group, levels of degradation product of type I collagen, N-terminal propeptide of type I procollagen, n-terminal middle molecular fragment of osteocalcin, serum phosphorus and alkaline phosphatase in the trial group were significantly increased (all P < 0.05). Based on the presence or absence of the disease, according to binary Logistic regression analysis, degradation product of type I collagen, N-terminal propeptide of type I procollagen, and n-terminal middle molecular fragment of osteocalcin were independent factors associated with osteonecrosis of the femoral head. The levels of degradation product of type I collagen and N-terminal propeptide of type I procollagen in three groups of patients with different etiologies were higher than normal reference values. The bone metabolism-regulating hormone 25-hydroxyvitamin D and serum calcium in the alcoholic osteonecrosis of the femoral head group were higher than those in the other two groups (P < 0.05). The level of bone metabolism-regulating hormone 25-hydroxyvitamin D in steroid-induced and traumatic osteonecrosis of the femoral head groups was lower than the normal value. There were no significant differences in seven bone metabolism-related indicators in patients with ARCO stages II, III and IV osteonecrosis of the femoral head (all P > 0.05), but degradation product of type I collagen and N-terminal propeptide of type I procollagen in these three groups were higher than normal reference values. Bone metabolism-regulating hormone 25-hydroxyvitamin D in patients with ARCO stage II and ARCO stage IV was lower than the normal reference value. It is concluded that the bone metabolism level of osteonecrosis of the femoral head patients was abnormal. The degradation product of type I collagen and N-terminal propeptide of type I procollagen of osteonecrosis of the femoral head patients with different etiologies and ARCO stages were all higher than the normal reference value, and they were in a state of high bone turnover. Degradation product of type I collagen, N-terminal propeptide of type I procollagen and n-terminal middle molecular fragment of osteocalcin may be risk factors for the pathogenesis of osteonecrosis of the femoral head.

Key words: osteonecrosis of the femoral head, bone metabolism, etiology, ARCO stage, N-terminal propeptide of type I procollagen

CLC Number:

Chen Ligang, He Xiaoming, Tan Yu, Xiao Yuzhi, Ma Chuntao, Guo Liang. Bone metabolism in patients with osteonecrosis of the femoral head based on etiology and Association Research Circulation Osseous staging[J]. Chinese Journal of Tissue Engineering Research, 2024, 28(16): 2461-2466.

Figures/Tables 6

References

[1] MONT MA, SALEM HS, PIUZZI NS, et al. Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today: A 5-Year Update. J Bone Joint Surg Am. 2020;102(12):1084-1099.
[2] CUI L, ZHUANG Q, LIN J, et al. Multicentric epidemiologic study on six thousand three hundred and ninety five cases of femoral head osteonecrosis in China. Int Orthop. 2016;40(2):267-276.
[3] 何伟. 如何把握股骨头坏死患者的保髋治疗时机[J]. 中国骨与关节杂志,2016,5(2):82-86.
[4] SHI Z, JIN H, DING Q, et al. Bone turnover markers may predict the progression of osteonecrosis of the femoral head in aged males. Ann Transl Med. 2019;7(22):626.
[5] ARAI R, TAKAHASHI D, INOUE M, et al. Efficacy of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head: a retrospective comparative study with alendronate. BMC Musculoskelet Disord. 2017;18(1):24.
[6] HERNIGOU P, FLOUZAT-LACHANIETTE CH, DELAMBRE J, et al. Osteonecrosis repair with bone marrow cell therapies: state of the clinical art. Bone. 2015;70:102-109.
[7] YOON BH, MONT MA, KOO KH, et al. The 2019 Revised Version of Association Research Circulation Osseous Staging System of Osteonecrosis of the Femoral Head. J Arthroplasty. 2020;35(4): 933-940.
[8] 中国医师协会骨科医师分会骨循环与骨坏死专业委员会,中华医学会骨科分会骨显微修复学组,国际骨循环学会中国区 .中国成人股骨头坏死临床诊疗指南(2020)[J]. 中华骨科杂志,2020,40(20): 1365-1376.
[9] GOLOB AL, LAYA MB. Osteoporosis: screening, prevention, and management. Med Clin North Am. 2015;99(3):587-606.
[10] XIAO W, WANG Y, PACIOS S, et al. Cellular and Molecular Aspects of Bone Remodeling. Front Oral Biol. 2016;18:9-16.
[11] GLENDENNING P, CHUBB S, VASIKARAN S. Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adults. Clin Chim Acta. 2018;481:161-170.
[12] FANG S, LI Y, CHEN P. Osteogenic effect of bone marrow mesenchymal stem cell-derived exosomes on steroid-induced osteonecrosis of the femoral head. Drug Des Devel Ther. 2019;13:45-55.
[13] MUTIJIMA E, DE MAERTELAER V, DEPREZ M, et al. The apoptosis of osteoblasts and osteocytes in femoral head osteonecrosis: its specificity and its distribution. Clin Rheumatol. 2014;33(12):1791-1795.
[14] 张萌萌,毛未贤,高远,等. ON、PINP、OPG、IGF-1、TGF-β与股骨颈BMD相关性研究[J]. 中国骨质疏松杂志,2014,20(8):880-884.
[15] 董松格. 激素性股骨头坏死患者血清PINP、CTX、OST的变化及意义[D]. 泰安:泰山医学院,2013.
[16] HAN L, WANG B, WANG R, et al. The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor. Stem Cell Res Ther. 2019; 10(1):377.
[17] 魏秋实,杨帆,陈哓俊,等. 激素性与酒精性股骨头坏死患者骨标本坏死区域病理与显微结构特点分析[J]. 中国修复重建外科杂志, 2018,32(7):866-872.
[18] 刘军川,薛庆云,文良元,等. 老年髋部骨质疏松性骨折患者早期骨代谢的前瞻性研究[J]. 中国骨与关节杂志,2018,7(3):163-167.
[19] 许昊,李毅中,庄华烽,等. 血清25羟维生素D水平与脆性髋部骨折关系的研究[J]. 中国骨质疏松杂志,2020,26(3):340-344.
[20] CHEN XT, ZHU YJ, LIU YW, et al. Metal trabecular bone reconstruction system better improves clinical efficacy and biomechanical repair of osteonecrosis of the femoral head than free vascularized fibular graft: A case-control study. J Cell Physiol. 2019;234(11):20957-20968.
[21] 付强,郑宝森. 早期股骨头缺血性坏死患者脂联素、CRP、TNF-α及NO水平与骨髓水肿和疼痛分级的相关性研究[J]. 中国实验诊断学,2015,19(10):1783-1785.
[22] ZHAO H, YEERSHENG R, XIA Y, et al. Hypoxia Enhanced Bone Regeneration Through the HIF-1alpha/beta-Catenin Pathway in Femoral Head Osteonecrosis. Am J Med Sci. 2021;362(1):78-91.
[23] LEE YK, HA YC, CHO YJ, et al. Does Zoledronate Prevent Femoral Head Collapse from Osteonecrosis? A Prospective, Randomized, Open-Label, Multicenter Study. J Bone Joint Surg Am. 2015;97(14):1142-1148.
[24] LEBOFF MS, GREENSPAN SL, INSOGNA KL, et al. The clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33(10):2049-2102.
[25] CHEVALLEY T, BRANDI ML, CASHMAN KD, et al. Role of vitamin D supplementation in the management of musculoskeletal diseases:update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res. 2022;34(11):2603-2623.
[26] 尧光学. 维生素D与激素性股骨头坏死骨代谢相关性初步探究[D]. 广州:广州中医药大学,2016.
[27] TIAN L, BAEK SH, JANG J, et al. Imbalanced bone turnover markers and low bone mineral density in patients with osteonecrosis of the femoral head. Int Orthop. 2018;42(7):1545-1549.
[28] KAMAL KC, ALEXANDRU DO, ROGOVEANU OC, et al. Immunohistochemical analysis of bone metabolism in osteonecrosis of the femoral head. Rom J Morphol Embryol. 2018;59(3):819-824.
[29] CRIM J, LAYFIELD LJ, STENSBY JD, et al. Comparison of Radiographic and Pathologic Diagnosis of Osteonecrosis of the Femoral Head. AJR Am J Roentgenol. 2021;216(4):1014-1021.
[30] WANG P, WANG C, MENG H, et al. The Role of Structural Deterioration and Biomechanical Changes of the Necrotic Lesion in Collapse Mechanism of Osteonecrosis of the Femoral Head. Orthop Surg. 2022; 14(5):831-839.